Table 1.

Dilution of stock iohexol (Omnipaque300) to working solutions

Diluted stock concentrations	Final experiment concentration	Final iodine content (mg/ml)
100%	80%	240
50%	40%	120
25%	20%	60
12.5%	10%	30
0%	0%	0

The diluted stock concentrations were 100%, 50%, 25%, 12.5% and 0% dilutions of Omnipaque300 (GE Healthcare NDC 0407–1413–86, iohexol injection, iodine content 300mg/ml) in complete media. Human platelet lysate expanded AMSCs in complete media were mixed with treatment solutions at the ratio of 1:4. Final experimental concentrations are shown as the final percentage of iohexol diluted into complete media.